According to a new report published by Allied Market Research, titled, “Implantable Medical Devices Market,” The implantable medical devices market was valued at $91,868.94 million in 2020, and is estimated to reach $179.0 Billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.
Rise in prevalence of chronic diseases coupled with the rapidly ageing population, surge in cardiovascular & neurological illnesses, and improvements in active implanted medical devices drive the growth of the global implantable medical devices market. On the other hand, high implantation cost and lack of trained professionals in the medical surgeries sector restrain the growth to some extent. However, increase in the investments & funds to develop technologically advanced products is expected to create lucrative opportunities in the industry.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/492
An implant is a medical device, which is used to replace or support any damaged body organs, improve the functioning of body organs, or treat defects in normal body functions. These can be surgically implanted either permanently or temporarily in the human body, and can be removed when dispensable. These implantable devices comprise bones, tissues, skin, ceramics, metals, plastics, and other natural materials. Medical implants are used to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure.
The orthopedic implants segment held the lion’s share-
Based on product, the orthopedic implants segment held the major share in 2020, generating more than one-fourth of the global implantable medical devices market. The dental implants segment, on the other hand, is projected to cite the fastest CAGR of 8.1% during the forecast period, due to surge in cardiovascular & neurological illnesses, and improvements in active implanted medical devices.
North America held the major share-
Based on region, the market across North America accounted for the highest share in 2020, contributing to more than two-fifths of the global implantable medical devices market, owing to increase in demand for implantable medical devices for the treatment of several diseases & disabilities and availability of advanced healthcare facilities with trained medical professionals. However, Asia-Pacific is expected to cite the fastest CAGR of 8.6% throughout the forecast period, attributed to rise in the prevalence of various diseases and increase in R&D investments in the developing countries such as Japan and China.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/492
Prominent market players-
- Biotronik SE and Co. KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- CONMED Corporation
- Abbott Laboratories
- Integra LifeSciences Holdings Corporation
- LivaNova PLC
- Johnson and Johnson
- Globus Medical Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the implantable medical devices market analysis from 2020 to 2030 to identify the prevailing implantable medical devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the implantable medical devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global implantable medical devices market trends, key players, market segments, application areas, and market growth strategies.
Read More:
Influenza Vaccine Market registering a CAGR of 7.20% from 2021 to 2030
Tissue Expanders Market is growing at a CAGR of 5.8% from 2022 to 2031.
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
